Literature DB >> 10577581

Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis.

G N Holland1, C Muccioli, C Silveira, J M Weisz, R Belfort, G R O'Connor.   

Abstract

PURPOSE: To describe the occurrence of intraocular inflammatory reactions as the sole ophthalmic manifestation of acquired systemic toxoplasmosis.
METHODS: Review of medical records for 10 patients with uveitis and evidence of recent Toxoplasma gondii infection.
RESULTS: Patient ages ranged from 3 to 51 years. Ocular symptoms were present in each of eight adult patients. Inflammation was unilateral in nine patients; it manifested as vitreous humor cells and haze (10 patients), anterior chamber cells (seven patients), and retinal vasculitis (seven patients). No patient had necrotizing retinochoroiditis upon initial examination. Inflammation resolved in each of nine patients who had follow-up examinations. Foci of retinitis or inactive retinochoroidal scars were seen in four of these nine patients during follow-up examinations, at intervals of 2.0 weeks to 2.5 years after initial examination.
CONCLUSIONS: Retinal vasculitis and associated inflammatory reactions may be the only ophthalmic disorder during the early stages of a newly acquired T. gondii infection. Later development of retinitis or scars consistent with toxoplasmic retinochoroiditis in the same eyes suggests that the initial, isolated inflammation may be caused by the presence of parasites in retinal tissue. These cases may have implications for understanding the original source of retinal infection in patients who have recurrent toxoplasmic retinochoroiditis and for treatment of newly acquired T gondii infection.

Entities:  

Mesh:

Year:  1999        PMID: 10577581     DOI: 10.1016/s0002-9394(99)00300-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Primary intraocular (retinal) lymphoma after ocular toxoplasmosis.

Authors:  Theodor C Sauer; Sanford M Meyers; Defen Shen; Sara Vegh; Charles Vygantas; Chi-Chao Chan
Journal:  Retin Cases Brief Rep       Date:  2010

2.  Hypertensive iridocyclitis.

Authors:  E C Kim; T P Margolis
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

3.  Infectious causes of posterior uveitis and panuveitis in Thailand.

Authors:  Natedao Kongyai; Kessara Pathanapitoon; Wasna Sirirungsi; Paradee Kunavisarut; Jolanda D F de Groot-Mijnes; Aniki Rothova
Journal:  Jpn J Ophthalmol       Date:  2012-04-28       Impact factor: 2.447

Review 4.  Toxoplasmosis: A history of clinical observations.

Authors:  Louis M Weiss; Jitender P Dubey
Journal:  Int J Parasitol       Date:  2009-02-13       Impact factor: 3.981

5.  Viral causes of unexplained anterior uveitis in Thailand.

Authors:  N Kongyai; W Sirirungsi; K Pathanapitoon; N Tananuvat; P Kunavisarut; P Leechanachai; J D F de Groot-Mijnes; A Rothova
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

6.  Role of molecular diagnostics in ocular microbiology.

Authors:  Parisa Taravati; Deborah Lam; Russell N Van Gelder
Journal:  Curr Ophthalmol Rep       Date:  2013-12-01

Review 7.  Ocular toxoplasmosis II: clinical features, pathology and management.

Authors:  Nicholas J Butler; João M Furtado; Kevin L Winthrop; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2012-09-17       Impact factor: 4.207

8.  Differential diagnosis of retinal vasculitis.

Authors:  Ahmed M Abu El-Asrar; Carl P Herbort; Khalid F Tabbara
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

9.  DNA chip-assisted diagnosis of a previously unknown etiology of intermediate uveitis- Toxoplasma gondii.

Authors:  Soumyava Basu; Savitri Sharma; Sarita Kar; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2010 Nov-Dec       Impact factor: 1.848

10.  Polymerase chain reaction in intraocular inflammation.

Authors:  Krishnendu Nandi; Prabhat Ranjan; Lily Therese; Jyotirmay Biswas
Journal:  Open Ophthalmol J       Date:  2008-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.